Acrux ARUXF Stock
Acrux Price Chart
Acrux ARUXF Financial and Trading Overview
| Acrux stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.02 USD |
| Bid | 0.0014 USD x 3000000 |
| Ask | 0.02 USD x 2000000 |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.0001 - 0.05 USD |
| Volume | 40K USD |
| Avg. Volume | 798 USD |
| Market Cap | 61.22K USD |
| Beta (5Y Monthly) | 1.02 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | August 18, 2015 |
| 1y Target Est | N/A |
ARUXF Valuation Measures
| Enterprise Value | 4.33M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.009301778 |
| Price/Book (mrq) | 0.047423255 |
| Enterprise Value/Revenue | 0.658 |
| Enterprise Value/EBITDA | -254.696 |
Trading Information
Acrux Stock Price History
| Beta (5Y Monthly) | 1.02 |
| 52-Week Change | -99.66% |
| S&P500 52-Week Change | 10.88% |
| 52 Week High | 0.05 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.003108 USD |
| 200-Day Moving Average | 0.00803045 USD |
ARUXF Share Statistics
| Avg. Volume (3 month) | 798 USD |
| Avg. Daily Volume (10-Days) | 1K USD |
| Shares Outstanding | 612.15M |
| Float | 389.69M |
| Short Ratio | N/A |
| % Held by Insiders | 23.14% |
| % Held by Institutions | 7.01% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | 441.00% |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | June 30, 2027 |
Profitability
| Profit Margin | -9.17% |
| Operating Margin (ttm) | 32.59% |
| Gross Margin | 84.18% |
| EBITDA Margin | -0.25% |
Management Effectiveness
| Return on Assets (ttm) | -1.93% |
| Return on Equity (ttm) | -48.51% |
Income Statement
| Revenue (ttm) | 6.58M USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | 10.80% |
| Gross Profit (ttm) | 5.54M USD |
| EBITDA | -17000 USD |
| Net Income Avi to Common (ttm) | -604000 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.71M USD |
| Total Cash Per Share (mrq) | 0.003 USD |
| Total Debt (mrq) | 2.52M USD |
| Total Debt/Equity (mrq) | 171.64 USD |
| Current Ratio (mrq) | 1.371 |
| Book Value Per Share (mrq) | 0.00210867 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.02M USD |
| Levered Free Cash Flow (ttm) | 1.13M USD |
Profile of Acrux
| Country | United States |
| State | VIC |
| City | West Melbourne |
| Address | 103-113, Stanley Street |
| ZIP | 3003 |
| Phone | 61 3 8379 0100 |
| Website | https://acrux.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Acrux Limited, together with its subsidiaries, develops and commercializes topically applied pharmaceutical products in Australia, the United States, Europe, and internationally. The company offers Dapsone 7.5% and 5% gels for the treatment of acne vulgaris; Nitroglycerine 0.4% ointments for the treatment of moderate to severe pain associated with chronic anal fissure; Lidocaine and Prilocaine creams USP 2.5% for local analgesia and pre-treatment for infiltration anesthesia; and estradiol transdermal sprays for women for the treatment of moderate to severe hot flushes associated with menopause under the Lenzetto and Evamist brand names. It also provides laboratory and product development services, including in vitro release testing; formulation development; stability and quality check; analytical; generic and pharma development; regulatory; project management and technology transfer; consulting; and co-development services. The company was incorporated in 1998 and is based in West Melbourne, Australia.
Q&A For Acrux Stock
What is a current ARUXF stock price?
Acrux ARUXF stock price today per share is 0.0001 USD.
How to purchase Acrux stock?
You can buy ARUXF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Acrux?
The stock symbol or ticker of Acrux is ARUXF.
Which industry does the Acrux company belong to?
The Acrux industry is Biotechnology.
How many shares does Acrux have in circulation?
The max supply of Acrux shares is 612.15M.
What is Acrux Price to Earnings Ratio (PE Ratio)?
Acrux PE Ratio is now.
What was Acrux earnings per share over the trailing 12 months (TTM)?
Acrux EPS is 0 USD over the trailing 12 months.
Which sector does the Acrux company belong to?
The Acrux sector is Healthcare.
